Table 1. Patient description and materials.
Patient | Mutation | Tissue (mtDNA) | Age | Reference |
---|---|---|---|---|
1 | POLG R3P/A467T | Skeletal muscle | 60 | (13) |
2 | POLG Y955C | Skeletal muscle | 48 | (13) |
3 | POLG Y955C | Skeletal muscle | 39 | (24) |
4a | POLG N468D/A1105T | Skeletal muscle | 50 | (24) |
5a | POLG N468D/A1105T | Skeletal muscle | 44 | |
6a | POLG N468D/A1105T | Skeletal muscle | 34 | |
7a | 352–364 AA duplication Twinkle | Extraocular eye muscle | 73 | (23) |
8a | 352–364 AA duplication Twinkle | Skeletal muscle | 60 | |
8a | 352–364 AA duplication Twinkle | Frontal cortex | 60 | |
9a | 352–364 AA duplication Twinkle | Skeletal muscle | 33 | |
10a | 352–364 AA duplication Twinkle | Skeletal muscle | 31 | |
11a | 352–364 AA duplication Twinkle | Skeletal muscle | 20 | |
1L | POLG R3P/A467T | Blood lymphocytes | 60 | (13) |
2L | POLG Y955C | Blood lymphocytes | 48 | (13) |
Controls | ||||
Δ1 | Single mtDNA deletion | Skeletal muscle | 60 | |
Δ2 | Single mtDNA deletion | Skeletal muscle | 48 | |
Δ3 | Single mtDNA deletion | Skeletal muscle | 35 | |
Δ4 | Single mtDNA deletion | Skeletal muscle | 40 | |
Δ5 | Single mtDNA deletion | Skeletal muscle | 5 | |
1a | None | Skeletal muscle | 32 | |
2a | None | Skeletal muscle | 36 | |
3a | None | Skeletal muscle | 51 | |
4a | None | Skeletal muscle | 53 | |
5a | None | Skeletal muscle | 55 | |
6b | None | Skeletal muscle | 72 | |
7a | None | Skeletal muscle | 32 | |
8a | None | Skeletal muscle | 55 | |
9a | None | Skeletal muscle | 62 | |
10a | None | Skeletal muscle | 66 |
Age of patients refers to the age at the time of the biopsy.
aPatients and controls indicated in Figure 1.
bControl 6 is a distant paternal relative of the POLG N468D/A1105T family members. Patients 1–3 and all single deletion cases are unrelated.